Newswise — Irvine, Calif., June 9, 2015 — Brain inflammation caused by chronic nerve pain alters activity in regions that regulate mood and motivation, suggesting for the first time that a direct biophysical link exists between long-term pain and the depression, anxiety and substance abuse seen in more than half of these patients, UC Irvine and UCLA researchers report.
This breakthrough finding also points to new approaches for treating chronic pain, which is second only to bipolar disorder among illness-related causes of suicide. About a quarter of Americans suffer from chronic pain, making it the most common form of enduring illness for those under the age of 60. The Institute of Medicine estimates that this costs our society more than $635 billion per year.
In work with rodents, Catherine Cahill, associate professor of anesthesiology & perioperative care at UCI; Christopher Evans of UCLA’s Brain Research Institute; and colleagues discovered that pain-derived brain inflammation causes the accelerated growth and activation of immune cells called microglia. These cells trigger chemical signals within neurons that restrict the release of dopamine, a neurotransmitter that helps control the brain’s reward and pleasure centers.
The study also reveals why opioid drugs such as morphine can be ineffective against chronic pain. Morphine and its derivatives normally stimulate the release of dopamine. But in research on mice and rats in chronic pain, Cahill and her colleagues learned that these drugs failed to stimulate a dopamine response, resulting in impaired reward-motivated behavior.
Treating these animals in chronic pain with a drug that inhibits microglial activation restored dopamine release and reward-motivated behavior, Cahill said.
“For over 20 years, scientists have been trying to unlock the mechanisms at work that connect opioid use, pain relief, depression and addiction,” she added. “Our findings represent a paradigm shift which has broad implications that are not restricted to the problem of pain and may translate to other disorders.”
The results of the five-year study appear online in The Journal of Neuroscience.
Next, Cahill and her team aim to establish that pain-derived changes in human brain circuitry can account for mood disorders. “We have a drug compound that has the potential to normalize reward-like behavior,” she said, “and subsequent clinical research could then employ imaging studies to identify how the same disruption in reward circuitry found in rodents occurs in chronic pain patients.”
Source: University of California, Irvine
Although medication is the primary treatment for bipolar disorder, adding specific vitamins or supplements might provide additional relief from symptoms. Here’s what the research shows. Navigating treatment options beyond medications can be an important part of managing bipolar disorder, and vitamins and supplements may provide a supportive role. They not only have the potential to...
READ MORE
The presence of anger in bipolar disorder — which can range from mild irritation to intense rage — adds complexity, but knowing more about it can help better handle this common symptom. Dealing with the ups and downs of bipolar disorder is challenging, and the addition of anger further complicates matters. The suddenness and intensity...
READ MORE
Our understanding of bipolar disorder and its management has significantly evolved, with individuals actively participating in their own care. As history shows, we’ve come a long way. Though it’s impossible to trace the first case of bipolar depression or mania, much is known about the evolution of its identification and subsequent classification and naming as...
READ MORE
Julie A. Fast uses her extensive research and personal experience to offer strategies for managing bipolar disorder. Read more in this Q&A about how her insights can guide confident management and deepen our understanding of this brain-based illness. Julie A. Fast is a recognized authority in the mental health field. She is known for her...
READ MORE
U have had RSD/CRPS for 9 yrs…with much medication and spinal cord stimulator implant…
I received a new form of relief from pain once I started taking seroquil and Lamictal for bipolar type 1.
My body was also covered in RSD lesions which went away all but immediately after starting Seroquil.
My pain physician explained this is because it stopped the neurons from creating a physical response to the skin.
This study is on to something BIG and can’t wait for further advances in knowledge associated with disabiliting diseases such as RSD
I am doing an interventional procedure called “Coolief” to deal with the strain of my chronic low back situation. It’s a drain and I hope this thing works.